| Lots of variables but it probably is feasible depending on 4 factors: 1) Sourcing.
how many viable cancer immunotherapy startups are there 2) Due diligence
how good are you at separating the wheat from the chaff 3) Competition
how much seed investment are they receiving vs how much they require, it does sound like a niche market 4) Strategy what are the timeframes involved, when do you get to “realize” your investment, riding them out to IPO?, etc 5) how will you accelerate their growth, contacts, help them with their own strategy etc... Now these factors play into the success of the fund in their interactions. Example 1 and 2 are not ideal but 3 is a situation with little competition, you might be able to get better deals more equity.
Obviously a lot of domain knowledge is required but
if you are able to address these 5 things satisfactorily then you might easily find money chasing you. After that it’s just coming up with a good investment structure (ex. certain international investors seek tax sheltering), some lawyers and choosing limited partners. Shouldn’t be too hard especially given the level and recognition this gentleman should command in his industry. |